홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sarcosine → HCID 178444710, 화합물

HRID 1177004
인쇄

반응식

HRID 1177004 반응식
[CH3:1][C:2]([CH3:30])([CH3:29])[CH2:3][CH2:4][N:5]1[C:10](=[O:11])[C:9]([C:12]2[NH:17][C:16]3[CH:18]=[CH:19][C:20](I)=[CH:21][C:15]=3[S:14](=[O:24])(=[O:23])[N:13]=2)=[C:8]([OH:25])[C:7]2=[CH:26][CH:27]=[CH:28][N:6]12.[O-]P(OP(OP([O-])([O-])=O)([O-])=O)(=O)[O-].[K+].[K+].[K+].[K+].[K+].N(CC(O)=O)C.[CH3:55][S:56]([NH2:59])(=[O:58])=[O:57]>[Cu]I.CN(C)C=O>[CH3:1][C:2]([CH3:30])([CH3:29])[CH2:3][CH2:4][N:5]1[C:10](=[O:11])[C:9]([C:12]2[NH:17][C:16]3[CH:18]=[CH:19][C:20]([NH:59][S:56]([CH3:55])(=[O:58])=[O:57])=[CH:21][C:15]=3[S:14](=[O:24])(=[O:23])[N:13]=2)=[C:8]([OH:25])[C:7]2=[CH:26][CH:27]=[CH:28][N:6]12
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 1088SarcosineHCID 61695Pentapotassium TriphosphateHCID 72879MethanesulfonamideHCID 178444709HCID 178444709, 화합물

생성물 1

HCID 178444710HCID 178444710, 화합물수율 51%

시약·촉매·용매 2

HCID 24350
Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)
촉매
HCID 6228Dimethylformamide용매

실험 절차

1-(3,3-Dimethyl-butyl)-4-hydroxy-3-(7-iodo-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-3-yl)-pyrrolo[1,2-b]pyridazin-2-one (Example 4d, 0.065 g, 0.120 mmol), potassium triphosphate (0.128 g, 0.60 mmol), sarcosine (0.006 g, 0.072 mmol), and copper (I) iodide (0.006 g, 0.03 mmol) were combined. Anhydrous N,N-dimethylformamide (2 mL) was added followed by methanesulfonamide (0.114 g, 1.2 mmol). The solution was degassed while stirring under vacuum and the flask was purged with nitrogen. The mixture was stirred at 100° C. for 2 h. Upon cooling, the mixture was diluted with ethyl acetate (100 mL), washed with 1.0 M aqueous hydrochloric acid solution (3×50 mL) and dried over magnesium sulfate. The entire organic layer was passed through a plug of silica gel. The filtrate was concentrated in vacuo to afford a solid. The solid was triturated with a 1:1 mixture of ethyl acetate and hexanes, collected by vacuum filtration, triturated with methanol and collected by vacuum filtration. The solid was dried in vacuo for 16 h to afford the desired product, N-{3-[1-(3,3-dimethyl-butyl)-4-hydroxy-2-oxo-1,2-dihydro-pyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide (0.031 g, 0.061 mmol, 51% yield) as a pale yellow powder. 1H NMR (400 MHz, DMSO-d6) δ: 1.01 (9H, s), 1.57-1.62 (2H, m), 3.07 (3H, s), 4.39-4.43 (2H, m), 6.70-6.72 (1H, m), 7.03 (1H, d, J=3.8 Hz), 7.53 (1H, dd, J1=8.7 Hz, J2=2.8 Hz), 7.60 (1H, d, J=2.3 Hz), 7.67 (1H, d, J=8.4 Hz), 7.75 (1H, s), 10.20 (1H, s), 13.72 (1H, bs). LC-MS (ESI) calcd for C21H25N5O6S2. found 507.12. found 508.36 [M+H+].

후처리

  1. customThe solution was degassed
  2. customthe flask was purged with nitrogen
  3. stirringThe mixture was stirred at 100° C. for 2 h
  4. temperatureUpon cooling
  5. additionthe mixture was diluted with ethyl acetate (100 mL)
  6. washwashed with 1.0 M aqueous hydrochloric acid solution (3×50 mL)
  7. dry with materialdried over magnesium sulfate
  8. concentrationThe filtrate was concentrated in vacuo
  9. customto afford a solid
  10. customThe solid was triturated with a 1:1 mixture of ethyl acetate and hexanes
  11. filtrationcollected by vacuum filtration
  12. customtriturated with methanol
  13. filtrationcollected by vacuum filtration
  14. customThe solid was dried in vacuo for 16 h

출처 및 근거

ORD 기록
ord-8bf1bfa87a2d49edace3badd88c9383c
출처 데이터셋
uspto-grants-2010_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07842838B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트